Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-31
2010-12-21
McGarry, Sean R (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S375000, C435S377000, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
07855184
ABSTRACT:
A pharmaceutical composition blocks angiogenesis and contains as an active agent at least one nucleotide sequence from nucleic acid molecule SEQ ID NO. 3, fragments thereof containing at least twelve contiguous nucleotides and derivatives thereof; and nucleic acid sequences containing at least twelve contiguous nucleotides of the nucleic acid molecule SEQ ID NO 30 and derivatives thereof.
REFERENCES:
patent: 5998148 (1999-12-01), Bennett et al.
patent: 1 010 433 (2000-06-01), None
patent: 92/13083 (1992-08-01), None
patent: 96/35791 (1996-11-01), None
Consuelo D'Ambrosio et al.,Transforming Potential of the Insulin Receptor Substrate I1, Cell Growth & Differentiation, vol. 6, May 1995, pp. 557-562.
Ewa Surmacz et al.,Overexpression of Insulin Receptor Substrate 1(IRS-I)in the Human Breast Cancer Cell Line MCF-7 Induces Loss of Estrogen Requirements for Growth and Transformation,Clinical Cancer Research, vol. 1, Nov. 1995, pp. 1429-1436.
William C. Wallace et al.,Amyloid Precursor Protein Requires the Insulin Signaling Pathway for Neurotrophic Activity,Molecular Brain Research, 1997, vol. 52, pp. 213-227.
Gert Wolf et al.,PTB Domains of IRS-1 and She Have Distinct but Overlapping Binding Specificities,The Journal of Biological Chemistry, Nov. 1995, vol. 270(46), pp. 27407-27410.
Mary K. Nolan et al.,Differential Roles of IRS-1 and SHC Signaling Pathways in Breast Cancer Cells,Int. J. Cancer, 1997, vol. 72, pp. 828-834.
Gene Signal International SA
McGarry Sean R
Young & Thompson
LandOfFree
Antisense oligonucleotides capable of inhibiting the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides capable of inhibiting the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides capable of inhibiting the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196221